Nitin Hingankar
Overview
Explore the profile of Nitin Hingankar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deshpande S, Ansari M, Sutar J, Das P, Hingankar N, Mukherjee S, et al.
Microbiol Spectr
. 2023 Mar;
:e0433222.
PMID: 36946746
Understanding the quality of immune repertoire triggered during natural infection can provide vital clues that form the basis for development of a humoral immune response in some individuals capable of...
2.
Hingankar N, Deshpande S, Das P, Rizvi Z, Wibmer C, Mashilo P, et al.
PLoS Pathog
. 2022 Apr;
18(4):e1010465.
PMID: 35482816
Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet...
3.
Sutar J, Deshpande S, Mullick R, Hingankar N, Patel V, Bhattacharya J
PLoS One
. 2021 May;
16(5):e0251969.
PMID: 34029329
Evolving diversity in globally circulating HIV-1 subtypes presents a formidable challenge in defining and developing neutralizing antibodies for prevention and treatment. HIV-1 subtype C is responsible for majority of global...
4.
Mullick R, Sutar J, Hingankar N, Deshpande S, Thakar M, Sahay S, et al.
Retrovirology
. 2021 May;
18(1):12.
PMID: 33990195
Background: The potential use of the broadly neutralizing monoclonal antibodies (bnAbs) towards prophylaxis and treatment to HIV-1 is currently being explored. While a number of promising bnAbs have been discovered...
5.
Kumar R, Deshpande S, Sewall L, Ozorowski G, Cottrell C, Lee W, et al.
PLoS Pathog
. 2021 Apr;
17(4):e1008977.
PMID: 33826683
Evaluating the structure-function relationship of viral envelope (Env) evolution and the development of broadly cross-neutralizing antibodies (bnAbs) in natural infection can inform rational immunogen design. In the present study, we...
6.
Rakshit S, Hingankar N, Alampalli S, Adiga V, Sundararaj B, Sahoo P, et al.
Cell Rep
. 2020 Dec;
33(9):108451.
PMID: 33264614
HIV infection predisposes latent tuberculosis-infected (LTBI) subjects to active TB. This study is designed to determine whether HIV infection of LTBI subjects compromises the balanced Mycobacterium tuberculosis (Mtb)-specific T helper...
7.
Sutar J, Padwal V, Sonawani A, Nagar V, Patil P, Kulkarni B, et al.
Virus Res
. 2019 Sep;
273:197763.
PMID: 31553924
Human Immunodeficiency Virus-1 Clade C (HIV-1C) dominates the AIDS epidemic in India, afflicting 2.1 million individuals within the country and more than 15 million people worldwide. Membrane proximal external region...
8.
Gupta A, Saple D, Nadkarni G, Shah B, Vaidya S, Hingankar N, et al.
AIDS Res Hum Retroviruses
. 2010 Jan;
26(1):25-31.
PMID: 20063995
HIV-infected patients receiving antiretroviral (ARV) therapy (ART) in India are not all adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in three private clinics in Mumbai,...
9.
Wani A, Ahanger S, Bapat S, Rangrez A, Hingankar N, Suresh C, et al.
PLoS One
. 2007 Sep;
2(9):e942.
PMID: 17895983
Background: Mitochondrial encephalomyopathies are a heterogeneous group of clinical disorders generally caused due to mutations in either mitochondrial DNA (mtDNA) or nuclear genes encoding oxidative phosphorylation (OXPHOS). We analyzed the...